AMBIXX
ActiveSummary
AMBIXX has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4.0m and a net result of -€195,005. The figures fluctuate too strongly year-on-year for a reliable trend projection. The computed 12-month bankruptcy probability is 1.0% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability13▼-69
Solvency100=
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
1.0%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €230,000 at 30 days acceptable
Liquidity ample (current ratio 4.03 against 3.8 in 2024; short-term debt: 4.4% and cash: 0.4% of total assets), and 10.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
89.5%
Return on assets
-4.4%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
69 d early
2023
30 d late
2022
3 d early
2021
25 d late
2020
27 d late
2019
20 d late
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 7 accounts on average 9 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 25 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€4.0m▼ 4.7%
2024 · €4.2m
Total assets
€4.4m▼ 10.1%
2024 · €4.9m
Net result
-€195,005
2024 · €535,946
Working capital
€589,279▼ 34.3%
2024 · €897,164
Trend over the years
In euros
In euros
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€0.07m▼ 39.5%€0.4m€0.2m▼ 49.2%-€0.003m-€0.1m▼ 3,901%
Net result-€0.07m▼ 42.6%€0.4m€0.2m▼ 57.4%€0.5m▲ 233%-€0.2m
Equity-€0.2m▼ 84.7%€0.2m€0.4m▲ 75.0%€4.2m▲ 1,007%€4.0m▼ 4.7%
Total assets€0.6m▼ 9.4%€1.1m▲ 80.6%€1.3m▲ 17.9%€4.9m▲ 265%€4.4m▼ 10.1%
Debt€0.8m▲ 1.1%€0.9m▲ 16.7%€1.0m▲ 4.7%€0.8m▼ 21.0%€0.5m▼ 39.3%
Working capital€0.1m▼ 80.3%€0.3m▲ 195%€0.4m▲ 60.1%€0.9m▲ 99.6%€0.6m▼ 34.3%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €136,924 in 2025 against €3,423 in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.4m
Fixed assets
€3.6m ▼ 1.7%
Current assets
€783,823 ▼ 35.6%
Equity and liabilities €4.4m
Equity
€4.0m ▼ 4.7%
Debt
€466,314 ▼ 39.3%
Debt's share of the balance-sheet total falls from 15.6% to 10.5%. Equity and debt are lower.
Key figures and ratios
EBITDA
-€71,651▼
2024 · €61,993
Cash flow
-€129,732▼
2024 · €601,362
Current ratio
4.03▲
2024 · 3.80
Debt to equity
0.12▼
2024 · 0.19
ROE
-4.9%▼
2024 · 12.9%
ROA
-4.4%▼
2024 · 10.9%
Interest coverage
-1.24▼
2024 · 14.24
Debt ≤ 1 year
€194,544▼
2024 · €320,267
Debt > 1 year
€271,770▼
2024 · €448,312
Income taxes
€550▲
2024 · €296
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €32,065 | €56,646 | €68,202 | €65,416 | €65,273 | ▼ 0.2% |
| Other operating charges640/8 | €449 | €1,851 | €1,468 | €2,559 | €9,622 | ▲ 276% |
| Gross operating margin9900 | -€39,738 | €436,110 | €261,407 | €64,552 | -€62,029 | ▼ 196% |
| Operating profit (loss)9901 | -€72,251 | €377,614 | €191,737 | -€3,423 | -€136,924 | ▼ 3,901% |
| Financial income75/76B | €5 | €26 | €3 | €544,018 | €277 | ▼ 99.9% |
| Recurring financial income75 | €5 | €26 | €3 | €544,018 | €277 | ▼ 99.9% |
| Financial charges65/66B | €2,019 | €445 | €1,520 | €4,354 | €57,808 | ▲ 1,228% |
| Recurring financial charges65 | €381 | €445 | €1,520 | €4,354 | €57,808 | ▲ 1,228% |
| Non-recurring financial charges66B | €1,638 | - | - | - | - | - |
| Profit (loss) for the period before taxes9903 | -€74,265 | €377,195 | €190,221 | €536,242 | -€194,455 | ▼ 136% |
| Income taxes67/77 | €383 | - | €29,391 | €296 | €550 | ▲ 86.1% |
| Profit (loss) for the period9904 | -€74,648 | €377,195 | €160,830 | €535,946 | -€195,005 | ▼ 136% |
| Profit (loss) for the period to be appropriated9905 | -€74,648 | €377,195 | €160,830 | €535,946 | -€195,005 | ▼ 136% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €0.6m | €1.1m | €1.3m | €4.9m | €4.4m | ▼ 10.1% |
| Fixed assets21/28 | €0.4m | €0.6m | €0.5m | €3.7m | €3.6m | ▼ 1.7% |
| Intangible fixed assets21 | €0.4m | €0.6m | €0.5m | €0.4m | €0.4m | ▼ 14.9% |
| Tangible fixed assets22/27 | €0.009m | €0.005m | €0.002m | €0.003m | €0.004m | ▲ 41.0% |
| Plant, machinery and equipment23 | - | - | - | €0.001m | €0.002m | ▲ 108% |
| Furniture and vehicles24 | €0.009m | €0.005m | €0.002m | €0.002m | €0.002m | = |
| Financial fixed assets28 | €0.005m | €2 | €0.03m | €3.3m | €3.3m | = |
| Current assets29/58 | €0.2m | €0.6m | €0.8m | €1.2m | €0.8m | ▼ 35.6% |
| Amounts receivable after more than one year29 | - | - | - | €0.03m | - | - |
| Trade receivables290 | - | - | - | €0.03m | - | - |
| Amounts receivable within one year40/41 | €0.2m | €0.5m | €0.8m | €1.2m | €0.8m | ▼ 33.7% |
| Trade receivables40 | €0.2m | €0.4m | €0.7m | €0.4m | €0.2m | ▼ 43.1% |
| Other amounts receivable41 | €0.02m | €0.08m | €0.07m | €0.7m | €0.5m | ▼ 28.0% |
| Cash at bank and in hand54/58 | €0.01m | €0.05m | €0.002m | €0.04m | €0.02m | ▼ 52.4% |
| Deferred charges and accrued income490/1 | - | - | - | - | €0.001m | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €0.6m | €1.1m | €1.3m | €4.9m | €4.4m | ▼ 10.1% |
| Equity10/15 | -€0.2m | €0.2m | €0.4m | €4.2m | €4.0m | ▼ 4.7% |
| Contributions10/11 | €0.09m | €0.09m | €0.09m | €0.09m | €0.09m | = |
| Revaluation surpluses12 | - | - | - | €3.2m | €3.2m | = |
| Reserves13 | - | €0.1m | €0.3m | €0.8m | €0.6m | ▼ 23.8% |
| Distributable reserves133 | - | €0.1m | €0.3m | €0.8m | €0.6m | ▼ 23.8% |
| Profit (loss) carried forward14 | -€0.3m | - | - | - | - | - |
| Amounts payable17/49 | €0.8m | €0.9m | €1.0m | €0.8m | €0.5m | ▼ 39.3% |
| Amounts payable after more than one year17 | €0.7m | €0.6m | €0.6m | €0.4m | €0.3m | ▼ 39.4% |
| Financial debts170/4 | €0.7m | €0.6m | €0.6m | €0.4m | €0.3m | ▼ 39.4% |
| Amounts payable within one year42/48 | €0.1m | €0.3m | €0.4m | €0.3m | €0.2m | ▼ 39.3% |
| Current portion of amounts payable after more than one year42 | - | - | - | - | €0.1m | - |
| Trade debts44 | €0.07m | €0.2m | €0.2m | €0.2m | €0.008m | ▼ 96.0% |
| Suppliers440/4 | €0.07m | €0.2m | €0.2m | €0.2m | €0.008m | ▼ 96.0% |
| Taxes, remuneration and social security45 | €370 | €0.02m | €0.05m | €0.06m | €147 | ▼ 99.8% |
| Taxes450/3 | €370 | €0.02m | €0.05m | €0.06m | €147 | ▼ 99.8% |
| Other amounts payable47/48 | €0.06m | €0.07m | €0.1m | €0.07m | €0.09m | ▲ 32.8% |
| Accrued charges and deferred income492/3 | - | - | €0.008m | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€0.07m | €0.4m | €0.2m | €0.5m | -€0.2m | ▼ 136% |
| + Depreciation and write-downs630 | €0.03m | €0.06m | €0.07m | €0.07m | €0.07m | ▼ 0.2% |
| Operating cash flow (approximation) | -€0.04m | €0.4m | €0.2m | €0.6m | -€0.1m | ▼ 122% |
| Investment in fixed assets (approximation) | - | -€0.2m | -€0.03m | -€3.2m | -€0.002m | ▲ 100.0% |
| Change in cash | - | €0.04m | -€0.05m | €0.04m | -€0.02m | ▼ 156% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Weakest financial yearnet -€195,005
Net result drops to -€195,005, the lowest in the series.
23-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €535,946 ▲233%
Net result €535,946, the highest in the series.
31-12
Financial
Equity above €2mEq €4.2m ▲1,007%
3 profitable years in a row build equity to €4.2m.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
28-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Back to profitnet €377,195
Net result €377,195 after 4 loss-making years.
31-12
Financial
Equity above €200,000Eq €214,378
Equity rises from -€162,817 to €214,378.
25-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 25 days late
2021
27-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 27 days late
2020
31-12
Financial
Liquidity triplescurrent ratio 5.11
Current ratio from 1.91 to 5.11.
Show earlier events
20-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 20 days late
2019
26-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 26 days late
2018
18-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
19-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 4 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Brecht · 1 establishment unit since 2016
Ground area
485 m²
Building footprint
118 m²
Parcel 11333B0351/00R000, Flanders. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
AMBIXX
since 2016unit no. 2.252.426.013
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11333B0351/00R000 | Flanders | 485 m² | 1 · 117 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
3 holdings · 7 subsidiaries in the treeOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 3
-
100%
-
100%
-
66%
All subsidiaries, including indirect ones 7
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
E-pharma 100%3 subsidiaries
- Apotheek Cauwenbergh 100%
- Apotheek De Voogt 100%
- APOTHEEK ZWAANTJE 100%
- PHARMA UNITED 100%
MEDISYNALL 66%1 subsidiary
- Idealpharma 100%
According to the 2025 annual accounts of AMBIXX and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No directors read yet: 0 of 4 Gazette acts processed.
Company details
Identification
Legal formPrivate limited company
Founded07-04-2016
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
73120Media representation
E-invoicing
Reachable via Peppol
Peppol ID
0208:0651692322
Also
9925:BE0651692322
Registered
17-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.